13F
中

EHC ENCOMPASS HEALTH CORP

2026Q1 · CUSIP 29261A100 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
575
Δ holders QoQ
-17
Breadth percentile
Top 91%
Whale holders
231
Δ whales
-5
Inst. holding value
$9.1B
New positions
78
Closed positions
95
Price momentum (1Q)
-2.9%
Put / Call
6/4

Breadth history (34 quarters)

2018Q1: Δ+305 · h=345 2018Q2: Δ+38 · h=383 2018Q3: Δ+39 · h=422 2018Q4: Δ+17 · h=439 2019Q1: Δ-18 · h=421 2019Q2: Δ-33 · h=388 2019Q3: Δ-30 · h=358 2019Q4: Δ+33 · h=391 2020Q1: Δ-21 · h=370 2020Q2: Δ+7 · h=377 2020Q3: Δ-7 · h=370 2020Q4: Δ+28 · h=398 2021Q1: Δ-4 · h=394 2021Q2: Δ+10 · h=404 2021Q3: Δ+24 · h=428 2021Q4: Δ-24 · h=404 2022Q1: Δ-1 · h=403 2022Q2: Δ-12 · h=391 2022Q3: Δ-47 · h=344 2022Q4: Δ+31 · h=375 2023Q1: Δ+14 · h=389 2023Q2: Δ-5 · h=384 2023Q3: Δ+26 · h=410 2023Q4: Δ+23 · h=433 2024Q1: Δ+2 · h=435 2024Q2: Δ+42 · h=477 2024Q3: Δ+5 · h=482 2024Q4: Δ+62 · h=544 2025Q1: Δ-8 · h=536 2025Q2: Δ+70 · h=606 2025Q3: Δ-4 · h=602 2025Q4: Δ-10 · h=592 2026Q1: Δ-17 · h=575 2018Q1: holders=345 2018Q2: holders=383 2018Q3: holders=422 2018Q4: holders=439 2019Q1: holders=421 2019Q2: holders=388 2019Q3: holders=358 2019Q4: holders=391 2020Q1: holders=370 2020Q2: holders=377 2020Q3: holders=370 2020Q4: holders=398 2021Q1: holders=394 2021Q2: holders=404 2021Q3: holders=428 2021Q4: holders=404 2022Q1: holders=403 2022Q2: holders=391 2022Q3: holders=344 2022Q4: holders=375 2023Q1: holders=389 2023Q2: holders=384 2023Q3: holders=410 2023Q4: holders=433 2024Q1: holders=435 2024Q2: holders=477 2024Q3: holders=482 2024Q4: holders=544 2025Q1: holders=536 2025Q2: holders=606 2025Q3: holders=602 2025Q4: holders=592 2026Q1: holders=575 -305 -152.5 +0 +152.5 +305 309473637 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 12 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q2 Top 3% -5.5% -9.0%
2024Q4 Top 7% +18.8% +19.9%
2024Q2 Top 4% +14.4% +15.0%
2023Q3 Top 5% +16.2% +35.5%
2023Q1 Top 12% +13.9% +5.4%
2022Q4 Top 13% -1.2% +11.8%
2021Q3 Top 6% +8.0% +2.2%
2019Q4 Top 13% -14.7% -23.4%

Options Sentiment

Put holders
6
QoQ: +3
Call holders
4
QoQ: +2

See methodology →

Fundamentals

PE (TTM)
17.8
EPS (TTM)
$5.99
EPS YoY
+23.8%
Revenue (TTM)
$6.1B
Revenue YoY
+10.1%
Quarterly Revenue & EPS (4Y)
2022-06-30: $1.1B 2022-09-30: $1.1B 2022-12-31: $1.1B 2023-03-31: $1.2B 2023-06-30: $1.2B 2023-09-30: $1.2B 2023-12-31: $1.2B 2024-03-31: $1.3B 2024-06-30: $1.3B 2024-09-30: $1.4B 2024-12-31: $1.4B 2025-03-31: $1.5B 2025-06-30: $1.5B 2025-09-30: $1.5B 2025-12-31: $1.5B 2026-03-31: $1.6B 2022-06-30: EPS 0.49 2022-09-30: EPS 0.45 2022-12-31: EPS 0.89 2023-03-31: EPS 0.87 2023-06-30: EPS 0.90 2023-09-30: EPS 0.84 2023-12-31: EPS 0.86 2024-03-31: EPS 1.10 2024-06-30: EPS 1.12 2024-09-30: EPS 1.06 2024-12-31: EPS 1.18 2025-03-31: EPS 1.48 2025-06-30: EPS 1.39 2025-09-30: EPS 1.24 2025-12-31: EPS 1.43 2026-03-31: EPS 1.93 0B 0.8B 1.6B $B 0.00 1.06 2.12 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 22 2023-03-31: PE 222023-06-30: PE 22.22023-09-30: PE 17.92023-12-31: PE 20.82024-03-31: PE 22.72024-06-30: PE 22.32024-09-30: PE 23.62024-12-31: PE 22.42025-03-31: PE 24.82025-06-30: PE 23.42025-09-30: PE 21.32025-12-31: PE 19.82026-03-31: PE 17.8 16 21 26 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)